Outsourcing-pharma1d
Eli Lilly invests $3bn in injectable drug manufacturing facility
Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...
Outsourcing-pharma1d
AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3 results
“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...
Outsourcing-pharma6d
Mitsubishi teams up with Dewpoint in $480m ALS deal
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
Outsourcing-pharma6d
Top 5 radiopharmaceuticals startups with VC backing
Radiopharmaceuticals have also been the target of large partnership deals, including a recent $140 million partnership ...